GRAIL, Inc. Debt Securities Available For Sale Excluding Accrued Interest
GRAIL, Inc. (GRAL) had Debt Securities Available For Sale Excluding Accrued Interest of $859.53 million as of 2026-06-30, per its 10-Q filed 2026-08-06.
Financial Statements › Balance Sheet › Assets
us-gaap:DebtSecuritiesAvailableForSaleExcludingAccruedInterest · last filed 2026-08-06
- 2026-06-30: Debt Securities Available For Sale Excluding Accrued Interest $859.53M.
- 2026-03-31: Debt Securities Available For Sale Excluding Accrued Interest $820.31M.
- 2025-12-31: Debt Securities Available For Sale Excluding Accrued Interest $901.94M.
- 2025-09-30: Debt Securities Available For Sale Excluding Accrued Interest $538.17M.
| Period end | Debt Securities Available For Sale Excluding Accrued Interest |
|---|---|
| 2026-06-30 | $859.53M 10-Q · filed 2026-08-06 |
| 2026-03-31 | $820.31M 10-Q · filed 2026-05-07 |
| 2025-12-31 | $901.94M 10-Q · filed 2026-08-06 |
| 2025-09-30 | $538.17M 10-Q · filed 2025-11-13 |
| 2025-06-30 | $600.62M 10-Q · filed 2025-08-13 |
| 2025-03-31 | $672.60M 10-Q · filed 2025-05-14 |
| 2024-12-31 | $761.38M 10-K · filed 2026-03-12 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| RadNet, Inc. (RDNT) | United States | $5.611B | -229.65 |
| VERACYTE, INC. (VCYT) | United States | $3.904B | 41.21 |
| Celcuity Inc. (CELC) | United States | $3.887B | -22.62 |
| CareDx, Inc. (CDNA) | United States | $3.174B | 13.21 |
| Caris Life Sciences, Inc. (CAI) | United States | $9.119B | 47.87 |
| Fortrea Holdings Inc. (FTRE) | United States | $1.903B | -19.43 |
| Personalis, Inc. (PSNL) | United States | $1.769B | -13.30 |
| CASTLE BIOSCIENCES INC (CSTL) | United States | $1.074B | -37.45 |
| Lumexa Imaging Holdings, Inc. (LMRI) | United States | $0.951B | |
| Fulgent Genetics, Inc. (FLGT) | United States | $0.593B | -6.70 |